Conjunctivitis: Symptoms, Treatment & Nursing Precautions
Clinical quick-reference for ward and ambulatory teams: separate viral, bacterial, allergic, and STI-related patterns; match hygiene and isolation; know when topical antibiotics help; and escalate contact-lens and neonatal presentations that can hide sight-threatening keratitis.
Featured snippet
Conjunctivitis (pink eye) is inflammation of the conjunctiva—usually injected, teary or mattered eyes with irritation—from viral or bacterial infection, allergy, irritation, or sexually transmitted organisms after high-risk exposure. Most viral community cases resolve within roughly one to two weeks without antimicrobials; topical antibiotics target selected bacterial disease. Bedside priorities are rigorous hygiene, outbreak awareness, and rapid escalation when pain, vision change, photophobia, contact-lens use, or neonatal age suggests keratitis, uveitis, or gonococcal infection rather than benign conjunctivitis alone.
- Triage red-eye syndromes by pain severity, vision change, photophobia, and contact-lens history—those features outrank routine fever-only viral bundles and need same-day ophthalmology or emergency review rather than deferred clinic slots.
- Viral and many bacterial conjunctivitis courses improve without antibiotics; primary-care guidance (for example NICE CKS) favours supportive care first line and reserves topical antibacterials for severe bacterial features or other clear indications—document rationale when stewardship differs.
- Hyperacute, copious purulent infection or genital symptoms should trigger sexual-health pathways for gonococcal disease and dual antibiotic regimens per local protocol, not outpatient drops alone.
- Neonatal conjunctivitis remains time-critical because Neisseria gonorrhoeae and Chlamydia trachomatis can damage the globe; any sticky red eye in the first month of life needs urgent clinician assessment, not parental reassurance.
- Outbreak control leans on structured ocular hygiene teaching, patient education, dedicated towels or washcloths, and cohorting in long-term care when institutional policy requires—align signage with infection prevention leadership.
⚡ Quick Facts
💡 Clinical Pearl
Pre-auricular lymphadenopathy whispers “viral.” Tender nodes in front of the ear raise odds of adenoviral conjunctivitis and should temper automatic antibiotic starts, yet still pair with vision checks because clinical rules are imperfect at bedside.
📋 Contents
What is Conjunctivitis?
Conjunctivitis describes swelling and hyperemia of the transparent conjunctival membrane lining the globe and inner lids. Histology shows vascular dilatation, lymphocyte or neutrophil infiltration depending on cause, and sometimes membranous or pseudomembranous change during aggressive viral or bacterial infection. Most patients localize discomfort as scratchiness, fulness, or surplus tearing; vision is typically preserved until the cornea becomes secondarily involved.
From a nursing vantage, conjunctivitis is useful shorthand for surface ocular inflammation yet that phrase papers over dramatic differences in urgency—community adenovirus clusters require outbreak messaging, staphylococcal lid margin disease needs hygiene coaching, whereas Neisseria exposure mandates systemic antibiotics and sexual-health referral. Mechanism-aware triage drives whether isolation signage, antihistamine education, or emergency pathways dominate the plan.
Subtypes at the bedside
Pattern recognition reduces both antibiotic overuse and missed emergencies. Use the table as a scaffold, then reconcile with slit-lamp findings when available.
| Category | Typical clues | IPC / therapy emphasis |
|---|---|---|
| Viral (often adenoviral) | Bilateral redness, watery discharge, follicles, pre-auricular node tenderness, concurrent URI | Supportive care; avoid unnecessary antibiotics; reinforce hand hygiene and droplet precautions in outbreaks. |
| Bacterial | Mucopurulent matting, unilateral predominance possible, less itch | Topical antibacterials when severity warrants—often erythromycin ointment or fluoroquinolone drops per formulary; screen children for otitis co-infection. |
| Allergic | Intense itch, chemosis, seasonal triggers | Allergen avoidance, cold compresses, oral nonsedating antihistamines such as loratadine when appropriate, adjunct ocular drops per prescriber. |
| STI-related | Hyperacute purulence, rapid lid swelling, STI risk | Escalate for systemic anti-gonococcal therapy; add azithromycin-class chlamydia cover per guideline. |
| HSV epithelial | Dendritic keratitis on exam, prior cold sores | Antiviral therapy (acyclovir pathways) is physician-led—never empiric steroid monotherapy. |
On a small screen, swipe or scroll sideways to see the full table.
COVID-19 note: Conjunctival injection occasionally accompanies SARS-CoV-2 infection; apply respiratory precautions when systemic symptoms align.
Symptoms
Redness, foreign-body sensation, lacrimation, and morning crusting dominate lay descriptions. Nurses parse itch intensity, laterality timeline, contact-lens use, and ocular pain scores—superficial irritation differs from deep ache implying corneal or deeper segment involvement.
Typical features
- Mucoid or watery discharge varying by etiology; sticky lashes after sleep in bacterial cases.
- Mild photophobia without pronounced vision loss in uncomplicated conjunctival disease.
- Clustering among household, classroom, or long-term care contacts during viral waves.
Atypical or high-risk patterns
- Moderate–severe pain, focal corneal haze, or profuse watering in a lens wearer.
- Circumlimbal injection with deep aching—consider uveitis.
- Copious hyperpurulent drainage within hours—gonococcal conjunctivitis until disproven in at-risk adults.
Causes and Risk Factors
Viral pathogens—adenovirus chief among institutional outbreaks—spread via fingers, contaminated instruments, towels, or eye-drop vials, sometimes alongside seasonal influenza or other respiratory viruses. Bacterial isolates commonly include Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Moraxella catarrhalis, staphylococci, and sexually transmitted Neisseria gonorrhoeae plus chlamydia in neonates and sexually active adults. Allergic disease links to aeroallergens and atopic histamine physiology.
Modifiable contributors
- Poor contact-lens hygiene, overnight wear, or swimming in lenses.
- Inadequate hand hygiene before ocular care tasks.
- Unprotected sexual exposure raising STI conjunctivitis risk.
Host factors
- Age extremes—neonates with maternal STI exposure; older adults with dryer ocular surfaces.
- Atopic history intensifying allergic phenotypes.
How is it Diagnosed?
Clinical assessment
Measure visual acuity at triage when pain or photophobia exists; compare pupils; note whether injection is predominantly tarsal/limbal. Fluorescein staining and slit-lamp interpretation stay within optometry/ophthalmology scope—nurses escalate access rather than diagnosing dendrites alone.
Laboratory investigations
- Gram stain and bacterial culture for neonates, treatment failure, immunocompromise, or suspected hyperacute bacterial infection—follow laboratory collection standards.
- Viral culture or molecular panels support outbreak epidemiology yet seldom change initial bedside IPC when classic adenovirus is suspected.
- CRP may trend with systemic toxicity in infants but never replaces specialist examination.
Imaging
No routine imaging; orbital imaging follows suspected orbital cellulitis protocols coordinated with ENT/ophthalmology.
Bedside tools
Point-of-care adenovirus immunoassays exist in some clinics; nursing assists per protocol when stocked.
Differential Diagnoses
Benign conjunctival labels delay herpetic keratitis, angle-closure glaucoma, chemical injury, and iritis—each carries distinct interventions.
| Alternative | Distinguishing cues |
|---|---|
| Microbial keratitis (contact lens) | Disproportionate pain, focal epithelial defect, anterior chamber reaction |
| Acute anterior uveitis | Ciliary flush, deep ache, small pupil |
| Acute angle-closure glaucoma | Hard eye, headache, nausea, mid-dilated pupil |
| Chemical injury | Known splash timeline; immediate irrigation per protocol |
| Scleritis / episcleritis | Sectoral redness, tenderness—often systemic autoimmune workup |
On a small screen, swipe or scroll sideways to see the full table.
Treatment Options
Match therapy to mechanism. NICE CKS infective conjunctivitis guidance favours supportive measures first line and reserves topical antibacterials for cases with severe features or need for faster resolution; CDC HCP pages reinforce that viral pink eye typically does not require antibiotics. Align with local stewardship grids.
First-line management
- Cool compresses, preservative-free lubricants, eyelid cleansing with sterile saline or locally accepted boiled-cooled water.
- Remove contact lenses until an eye professional clears reuse; discard contaminated cases and solution.
- Topical antibacterials (e.g. ciprofloxacin drops where formulary supports) for selected bacterial disease—frequency and duration follow prescriber orders, often continuing through 48 hours after clinical resolution per regional standards.
Second-line / special situations
- Hyperacute gonococcal infection: urgent parenteral third-generation cephalosporin therapy plus chlamydia-directed oral therapy—managed as emergency medicine, not optician visit.
- Neonatal conjunctivitis: evaluate per paediatric bundles including prophylaxis documentation and admission criteria.
Special populations
- Pregnancy: verify medication safety before systemic anti-STI regimens.
- Immunocompromise: lower threshold for culture and specialist review.
Unprescribed topical steroids accelerate microbial and herpetic damage. Administer only on explicit ophthalmology orders; hold and escalate if acuity falls.
Clinical Practice Considerations
Bundle conjunctivitis care with IPC notifications, ophthalmology callback times, and pharmacy education on drop sterility.
- Monitoring intervals: inpatients reassess pain, secretions, and gross vision each shift; neonates follow unit-specific intensive schedules until stable.
- Treatment failure: worsening after 48–72 hours of appropriate topical therapy or new photophobia triggers urgent ophthalmology—not ad-hoc broader drops without prescription.
- Referral thresholds: painful lens-related red eye, infants under 30 days, penetrating injury suspicion, or immunocompromise.
Clinical decision flow
- Check acuity and pupils → any abnormality mandates rapid eye evaluation.
- Confirm lens status → pain plus lenses elevates keratitis probability.
- Flag contagious risk → place hygiene alerts per IPC.
- Neonate red eye → urgent clinician pathway.
Bedside monitoring checklist
- Serial photographs with consent when chemosis evolves.
- Temperature curve if periorbital swelling progresses—broaden differential.
- Confirm patients clean hands before drops to reduce autoinoculation.
Possible Complications
- Microbial keratitis with scar or perforation—especially among lens wearers.
- Immune subepithelial infiltrates after viral infection.
- Extension to preseptal or orbital cellulitis.
- Vision loss from inadequately treated neonatal gonococcal or chlamydial infection.
Prevention
Coach patients against sharing towels, cosmetics, or eye drops; replace mascara after infection; postpone swimming with active drainage. Facilities reinforce equipment disinfection during adenovirus season and glove use when handling copious secretions.
Prognosis and Outlook
Uncomplicated viral conjunctivitis usually resolves within one to two weeks without antimicrobials. Bacterial cases often improve within days once appropriate topical therapy covers the isolate. Outcomes for vision-threatening mimics depend on hours-to-care more than nursing accessory measures.
In Clinical Practice…
Therapeutic communication
Explain viral contagiousness without catastrophizing; pair return precautions with concrete vision-change triggers families can recognise at home.
Drop safety
Date multidose bottles at opening; prevent bottle-tip contact with lashes; discard per policy after infection resolution to avoid reinfection.
Documentation
Chart laterality, lens status, STI risk factors disclosed, IPC measures implemented, and education topics covered for continuity across shifts.
When to Seek Emergency Care
- Severe pain, marked photophobia, or dropping visual acuity.
- Contact-lens wearer with painful red eye—presume microbial keratitis pending exam.
- Neonatal conjunctivitis or any infant under roughly 30 days with purulent discharge.
- Hyperacute purulence with lid edema and systemic toxicity—possible gonococcal sepsis.
- Chemical exposure, penetrating injury, or symptoms suggestive of acute angle-closure glaucoma.
Nursing actions: initiate sepsis bundles if instability appears; coordinate urgent sexual-health care for suspected GC conjunctivitis; perform chemical irrigation only per institutional volume and pH-monitoring protocols.
NCLEX practice questions
These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of viral / bacterial / allergic / chemical / gonococcal / chlamydial conjunctivitis, contact-lens / neonatal / immunocompromised considerations and the keratitis / hyperacute-bacterial / acute-glaucoma / orbital-cellulitis red flags.
Unfolding case (Questions 1–3): Ms. L., 24, presents with 24 hours of bilateral red eyes, watering, foreign-body sensation and crusty discharge in the morning. No vision change, no severe pain, no photophobia, no contact lenses. Recent viral URTI in the family. Visual acuity 6/6 each eye, pupils equal and reactive, no corneal staining, no preauricular lymphadenopathy on right side.
Answer key & rationale
Does every red eye with discharge need immediate topical antibiotics?
No. Many episodes are viral and self-limiting; primary-care pathways often favour supportive care and reserve antibiotics for severe bacterial features, clinical uncertainty with meaningful downside risk, or specific contexts such as contact lens–related infection concern—always align with local formulary and prescriber judgment.
How long should schools or workplaces exclude people with infectious conjunctivitis?
Policies differ by jurisdiction and setting severity. Follow institutional occupational-health rules and public-health guidance; many children can continue activities when mild and systemically well, whereas high-transmission environments may require symptom-based return criteria—document instructions verbatim for families.
When is gonococcal conjunctivitis suspected in adults?
Rapidly progressive hyperpurulent disease, severe chemosis, systemic symptoms, or genitourinary exposure should trigger sexual-health pathways with systemic treatment planning rather than outpatient drops alone.
What follow-up window is reasonable if uncomplicated bacterial conjunctivitis is treated topically?
Many guidelines describe reassessment if not improving within about a week, sooner if vision changes, pain intensifies, or photophobia emerges; neonates always need accelerated timelines.
Should contact lenses be worn during treatment?
No—patients should discontinue lenses until an eye-care professional clears reuse; reinfection and corneal compromise risk rise when lenses return prematurely.
Are oral antihistamines sufficient for allergic conjunctivitis on the ward?
Systemic agents like nonsedating antihistamines help some patients but targeted ocular therapy and allergen control still matter; sedation and anticholinergic load limit high-dose sedating antihistamine use especially in older adults without monitoring.
Which laboratory tests help inpatient teams when orbital involvement is possible?
Bloodwork such as CRP may support systemic inflammation trend monitoring but never replaces bedside neuro-ocular checks and urgent imaging referral when orbital cellulitis is suspected; negative labs do not clear high-risk red-eye pathways.
How should nurses document contagious conjunctivitis for IPC bundles?
Record symptom onset, eye involvement laterality, isolation sign posting, dedicated equipment or single-patient disposable items, and reinforcement of hand hygiene before and after eye care—audits align with WHO five moments framing used across nursing units.
- Centers for Disease Control and Prevention. Conjunctivitis (pink eye): clinical overview for healthcare professionals.https://www.cdc.gov/conjunctivitis/hcp/clinical-overview/index.html
- Centers for Disease Control and Prevention. Causes of pink eye (conjunctivitis).https://www.cdc.gov/conjunctivitis/causes/index.html
- Centers for Disease Control and Prevention. Treatment for pink eye (conjunctivitis).https://www.cdc.gov/conjunctivitis/treatment/index.html
- Centers for Disease Control and Prevention. Pink eye (conjunctivitis) in newborns.https://www.cdc.gov/conjunctivitis/newborns/index.html
- National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summary: conjunctivitis – infective (scenario: management in primary care).https://cks.nice.org.uk/topics/conjunctivitis-infective/management/management-in-primary-care/
- National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summary: red eye (management).https://cks.nice.org.uk/topics/red-eye/management/
- Solano D, Fu L, Czyz CN. Viral conjunctivitis (StatPearls).https://www.ncbi.nlm.nih.gov/books/NBK470271/
- Pippin MM, Le JK. Bacterial conjunctivitis (StatPearls).https://www.ncbi.nlm.nih.gov/books/NBK546683/
- Makker K, Nassar GN, Kaufman EJ. Neonatal conjunctivitis (StatPearls).https://www.ncbi.nlm.nih.gov/books/NBK441840/
- NHS. Conjunctivitis (overview).https://www.nhs.uk/conditions/conjunctivitis/
- American Academy of Ophthalmology. Conjunctivitis: what is pink eye?https://www.aao.org/eye-health/diseases/pink-eye-conjunctivitis
